Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability
- PMID: 10681076
- DOI: 10.1001/archneur.57.2.191
Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability
Abstract
Background: Several clinical criteria have been developed to standardize the diagnosis of vascular dementia (VaD). Significant differences in patient classification have been reported, depending on the criteria used. Few studies have examined interrater reliability.
Objective: To assess the concordance in classification and interrater reliability for the following 4 clinical definitions of VaD: the Hachinski Ischemic Score (HIS), the Alzheimer Disease Diagnostic and Treatment Centers (ADDTC), National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN), and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).
Methods: Structured diagnostic checklists were developed for 4 criteria for VaD, 2 criteria for Alzheimer disease (AD), and 4 criteria for dementia. Twenty-five case vignettes, representing a spectrum of cognitive impairment and subtypes of dementia, were prepared in a standardized clinical format. Concordance in case classification using different criteria and interrater reliability among 7 ADDTCs given a specific set of criteria was assessed using the kappa statistic.
Results: The frequency of a diagnosis of VaD was highest using the modified HIS or DSM-IV criteria, intermediate using the original HIS and ADDTC criteria, and lowest using the NINDS-AIREN criteria. Scores for interrater reliability ranged from kappa = 0.30 (ADDTC) to kappa = 0.61 (original HIS).
Conclusions: Clinical criteria for VaD are not interchangeable. Depending on the criteria selected, the reported prevalence of VaD will vary significantly. The traditional HIS has higher interrater reliability than the newer criteria for VaD. Prospective longitudinal studies with clinical-pathological correlation are needed to compare validity.
Comment in
-
Criteria for vascular dementia: replacing dogma with data.Arch Neurol. 2000 Feb;57(2):170-1. doi: 10.1001/archneur.57.2.170. Arch Neurol. 2000. PMID: 10681073 No abstract available.
-
Criteria for diagnosis of vascular dementia.Arch Neurol. 2000 Sep;57(9):1382-3. doi: 10.1001/archneur.57.9.1382-a. Arch Neurol. 2000. PMID: 10987916 No abstract available.
Similar articles
-
Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences.Stroke. 2000 Dec;31(12):2952-7. doi: 10.1161/01.str.31.12.2952. Stroke. 2000. PMID: 11108755
-
Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia.Neurology. 1997 Sep;49(3):690-4. doi: 10.1212/wnl.49.3.690. Neurology. 1997. PMID: 9305324
-
The Vascular Behavioral and Cognitive Disorders criteria for vascular cognitive disorders: a validation study.Eur J Neurol. 2019 Sep;26(9):1161-1167. doi: 10.1111/ene.13960. Epub 2019 May 17. Eur J Neurol. 2019. PMID: 30927497
-
Comparability of the clinical diagnostic criteria for vascular dementia: a critical review. Part I.J Neuropsychiatry Clin Neurosci. 2008 Spring;20(2):150-61. doi: 10.1176/jnp.2008.20.2.150. J Neuropsychiatry Clin Neurosci. 2008. PMID: 18451186 Review.
-
Validity of the clinical diagnostic criteria for vascular dementia: a critical review. Part II.J Neuropsychiatry Clin Neurosci. 2008 Spring;20(2):162-77. doi: 10.1176/jnp.2008.20.2.162. J Neuropsychiatry Clin Neurosci. 2008. PMID: 18451187 Review.
Cited by
-
An Examination of the Joint Effect of the Social Environment and Air Pollution on Dementia Among US Older Adults.Environ Epidemiol. 2023 May 11;7(3):e250. doi: 10.1097/EE9.0000000000000250. eCollection 2023 Jun. Environ Epidemiol. 2023. PMID: 37304341 Free PMC article.
-
Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology.PLoS One. 2023 Jun 8;18(6):e0286812. doi: 10.1371/journal.pone.0286812. eCollection 2023. PLoS One. 2023. PMID: 37289845 Free PMC article.
-
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison.Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2200-2211. doi: 10.1007/s00259-021-05246-x. Epub 2021 Feb 27. Eur J Nucl Med Mol Imaging. 2021. PMID: 33638661 Free PMC article. Clinical Trial.
-
Impact of different methods defining post-stroke neurocognitive disorder: The Nor-COAST study.Alzheimers Dement (N Y). 2020 Mar 16;6(1):e12000. doi: 10.1002/trc2.12000. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 32211505 Free PMC article.
-
Relationship between fibrinogen level and its regulatory gene with Alzheimer's disease and vascular dementia.J Int Med Res. 2020 Feb;48(2):300060520902578. doi: 10.1177/0300060520902578. J Int Med Res. 2020. PMID: 32093517 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials